Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study

被引：0
|
作者：
Glauce Cordeiro Ulhôa Tostes
Maria Rosário Cunha
Rosa Tsumeshiro Fukui
Márcia Regina Silva Correia
Dalva Marreiro Rocha
Rosa Ferreira dos Santos
Maria Elizabeth Rossi da Silva
机构：
[1] Universidade de São Paulo,Laboratório de Carboidratos e Radioimunoensaios LIM
来源：
Diabetology & Metabolic Syndrome | / 8卷
关键词：
Nateglinide; Rosiglitazone; GLP-1; Haemostatic factors; Inflammatory markers; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Short-term effects of allulose consumption on glucose homeostasis, metabolic parameters, incretin levels, and inflammatory markers in patients with type 2 diabetes: a double-blind, randomized, controlled crossover clinical trial
    Preechasuk, Lukana
    Luksameejaroenchai, Chanoknan
    Tangjittipokin, Watip
    Kunavisarut, Tada
    EUROPEAN JOURNAL OF NUTRITION, 2023, 62 (07) : 2939 - 2948
  • [22] Short-term effects of glucagon-like peptide 1 (GLP-1) receptor agonists on fat distribution in patients with type 2 diabetes mellitus: an ultrasonography study
    Morano, Susanna
    Romagnoli, Elisabetta
    Filardi, Tiziana
    Nieddu, Luciano
    Mandosi, Elisabetta
    Fallarino, Mara
    Turinese, Irene
    Dagostino, Mariangela Pia
    Lenzi, Andrea
    Carnevale, Vincenzo
    ACTA DIABETOLOGICA, 2015, 52 (04) : 727 - 732
  • [23] Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes
    Hojberg, P. V.
    Vilsboll, T.
    Zander, M.
    Knop, F. K.
    Krarup, T.
    Volund, A.
    Holst, J. J.
    Madsbad, S.
    DIABETIC MEDICINE, 2008, 25 (11) : 1268 - 1275
  • [24] Efficacy and Safety of the Once-Weekly GLP-1 Receptor Agonist Albiglutide Versus Sitagliptin in Patients With Type 2 Diabetes and Renal Impairment: A Randomized Phase III Study
    Leiter, Lawrence A.
    Carr, Molly C.
    Stewart, Murray
    Jones-Leone, Angela
    Scott, Rhona
    Yang, Fred
    Handelsman, Yehuda
    DIABETES CARE, 2014, 37 (10) : 2723 - 2730
  • [25] The effects of sesame, canola, and sesame–canola oils on cardiometabolic markers in patients with type 2 diabetes: a triple-blind three-way randomized crossover clinical trial
    Mojgan Amiri
    Hamidreza Raeisi-Dehkordi
    Fatemeh Moghtaderi
    Alireza Zimorovat
    Matin Mohyadini
    Amin Salehi-Abargouei
    European Journal of Nutrition, 2022, 61 : 3499 - 3516
  • [26] Long-Term Clinical and Economic Effects of Switching to Once-Weekly Semaglutide from Other GLP-1 RAs Among Patients with Type 2 Diabetes in China: A Modeling Projection Study
    Hu, Ying
    Chen, Xianwen
    Zou, Huimin
    Zhang, Hao
    Ni, Qi
    Li, Yijun
    Ung, Carolina Oi Lam
    Hu, Hao
    Mu, Yiming
    ADVANCES IN THERAPY, 2025, 42 (02) : 904 - 917
  • [27] Prospective observational study evaluating the effects of GLP1-RA on Inflammatory Bowel Disease (IBD) in patients with Type 2 Diabetes Mellitus (TDM2)
    Piumatti, A.
    Beccuti, G.
    Armandi, A.
    Bugianesi, E.
    Broglio, F.
    Ribaldone, D. G.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1359 - I1359
  • [28] PROSPECTIVE OBSERVATIONAL STUDY EVALUATING THE EFFECTS OF GLP1-RAS ON INFLAMMATORY BOWEL DISEASE (IBD) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (TDM2)
    Piumatti, A.
    Armandi, A.
    Bugianesi, E.
    Beccuti, G.
    Broglio, F.
    Ribaldone, D. G.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S241 - S242
  • [29] Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus
    Vilsboll, T.
    Brock, B.
    Perrild, H.
    Levin, K.
    Lervang, H. -H.
    Kolendorf, K.
    Krarup, T.
    Schmitz, O.
    Zdravkovic, M.
    Le-Thi, T.
    Madsbad, S.
    DIABETIC MEDICINE, 2008, 25 (02) : 152 - 156
  • [30] Effects of Metformin on Postprandial Blood Pressure, Heart Rate, Gastric Emptying, GLP-1, and Prevalence of Postprandial Hypotension in Type 2 Diabetes: A Double-Blind Placebo-Controlled Crossover Study
    Quast, Daniel R.
    Xie, Cong
    Bound, Michelle J.
    Grivell, Jacqueline
    Hatzinikolas, Seva
    Jones, Karen L.
    Horowitz, Michael
    Rayner, Christopher K.
    Nauck, Michael A.
    Meier, Juris J.
    Phillips, Liza K.
    Wu, Tongzhi
    DIABETES, 2025, 74 (04) : 611 - 618
12345